On April 12, 2024 ImmunoGen had a market cap of NZ$15.24 Billion. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Marketcap | Change |
---|---|---|
2024 | NZ$15.46 B | 23.27% |
2023 | NZ$12.54 B | 627.68% |
2022 | NZ$1.72 B | -27.87% |
2021 | NZ$2.39 B | 37.37% |
2020 | NZ$1.74 B | 52.94% |
2019 | NZ$1.13 B | 6.45% |
2018 | NZ$1.06 B | -10.43% |
2017 | NZ$1.19 B | 364.26% |
2016 | NZ$0.25 B | -85.1% |
2015 | NZ$1.72 B | 157.51% |
2014 | NZ$0.67 B | -56.16% |
2013 | NZ$1.52 B | 17.15% |
2012 | NZ$1.30 B | 15.05% |
2011 | NZ$1.13 B | 38.9% |
2010 | NZ$0.81 B | 31.65% |
2009 | NZ$0.62 B | 65.17% |
2008 | NZ$0.37 B | 61.55% |
2007 | NZ$0.23 B | -22.44% |
2006 | NZ$0.29 B | -2.81% |
2005 | NZ$0.30 B | -39.04% |
2004 | NZ$0.50 B | 60.4% |
2003 | NZ$0.31 B | 26.15% |
2002 | NZ$0.24 B | -84.26% |
2001 | NZ$1.58 B |